A serum miRNAs signature for early diagnosis of bladder cancer
AbstractBackground Bladder cancer accounts for the most common type of urologic malignancy and presents high recurrence rate after surgical resection and adjuvant intravesical therapy. We aim to search for an early diagnostic biomarker in serum for bladder cancer in this study.Methods The expression...
Main Authors: | Zuhu Yu, Chong Lu, Yongqing Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2023.2172206 |
Similar Items
-
Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine
by: Jen-Tai Lin, et al.
Published: (2021-04-01) -
Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review
by: Anna Maria Grimaldi, et al.
Published: (2022-10-01) -
Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression
by: Cornelia Braicu, et al.
Published: (2019-10-01) -
Protein Binding Partners of Dysregulated miRNAs in Parkinson’s Disease Serum
by: Wolfgang P. Ruf, et al.
Published: (2021-04-01) -
MiRNA-QC-and-Diagnosis: An R package for diagnosis based on MiRNA expression
by: Michele Castelluzzo, et al.
Published: (2020-07-01)